The role of PC-1 and ACE genes in diabetic nephropathy in type 1 diabetic patients: evidence for a polygenic control of kidney disease progression

Nephrol Dial Transplant. 2002 Aug;17(8):1402-7. doi: 10.1093/ndt/17.8.1402.

Abstract

Background: The DD genotype of the ACE gene predisposes to faster diabetic nephropathy (DN) progression but its role in DN development is more controversial. We reported previously, in type 1 diabetic patients, an association between faster DN progression and the PC-1 gene Q121 variant, which associates with insulin resistance in non-diabetic subjects. We investigated here whether the combination of the ACE DD genotype and the PC-1 Q121 variant predicts the development and/or progression of DN in type 1 diabetic patients.

Methods: Type 1 diabetic patients either with (n=159) or without (n=122) nephropathy were evaluated in a cross-sectional study. DN was defined as the presence of microalbuminuria or persistent proteinuria in a subject with more than 10-year duration of disease and concomitant diabetic retinopathy, and with no evidence of heart failure or other renal disease. Seventy-five (47 male/28 female) type 1 diabetic patients with nephropathy in whom retrospective information with repeated measurements of serum creatinine was available, were analysed in a longitudinal study.

Results: No association of the PC-1 Q121 variant and the ACE D/D genotype with DN development was observed. However, the ACE DD genotype and the PC-1 Q121 variant were associated, both independently (P=0.02 and P=0.025, respectively) or in combination (P=0.02), with a faster rate of glomerular filtration rate decline. An interaction (P=0.03) was observed between the two genes in increasing the individual patient's risk of being a fast progressor.

Conclusion: Our data suggest that, in type 1 diabetic patients, the ACE and the PC-1 genes interact in increasing the individual risk of having a faster DN progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Age of Onset
  • Albuminuria
  • Blood Pressure
  • Cholesterol / blood
  • Cohort Studies
  • Creatinine / blood
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 1 / blood
  • Diabetes Mellitus, Type 1 / enzymology
  • Diabetes Mellitus, Type 1 / genetics*
  • Diabetic Nephropathies / blood
  • Diabetic Nephropathies / enzymology
  • Diabetic Nephropathies / genetics*
  • Disease Progression
  • Female
  • Genetic Variation
  • Glycated Hemoglobin / analysis
  • Humans
  • Male
  • Peptidyl-Dipeptidase A / genetics*
  • Phosphoric Diester Hydrolases / genetics*
  • Pyrophosphatases / genetics*
  • Triglycerides / blood

Substances

  • Glycated Hemoglobin A
  • Triglycerides
  • Cholesterol
  • Creatinine
  • Phosphoric Diester Hydrolases
  • ectonucleotide pyrophosphatase phosphodiesterase 1
  • Peptidyl-Dipeptidase A
  • Pyrophosphatases